Central retinal artery occlusion without cherry-red spots.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
25 Oct 2023
Historique:
received: 03 06 2023
accepted: 14 10 2023
medline: 27 10 2023
pubmed: 26 10 2023
entrez: 25 10 2023
Statut: epublish

Résumé

Cherry-red spots are a very important sign for the clinical diagnosis of central retinal artery occlusion (CRAO). We retrospectively summarized the clinical manifestations of CRAO and analysed the causes and characteristics of CRAO without cherry-red spots. In this study, we explored a diagnostic method for CRAO without cherry red spots. Seventy patients (70 eyes) with CRAO were examined retrospectively. Corrected distance visual acuity, fundus photos, FA and OCT images were collected at the first outpatient visit. The causes of CRAO without cherry-red spots were analysed through fundus photos. The incidence of increased hyperreflectivity of the inner retina, central macular thickness (CMT) and arteriovenous transit time in patients with and without cherry-red spots were compared. Fundus examination showed posterior retinal whitening in 57 cases (81.43%) and cherry-red spots in 39 cases (55.71%). Thirty-one patients presented at the first outpatient visit without cherry-red spots. The reasons for the absence of cherry-red spots included leopard fundus (32.26%), retinal vein occlusion (25.81%), no obvious inner retinal coagulative necrosis (19.35%), ciliary retinal artery sparing (12.90%), high macular oedema (9.68%) and cherry-red spot enlargement (3.23%). OCT revealed increased hyperreflectivity of the inner retina in 67 CRAO patients (95.71%). All 3 patients without increased hyperreflectivity of the inner retina did not present with cherry-red spots at the first visit. The median CMT in patients without cherry-red spots was 166.00 μm, while the median MCT in patients with cherry-red spots was 180.00 μm; there was no significant difference between these two groups (P = 0.467). FA showed delayed arteriovenous transit time > 23 s in 20 patients (28.57%), > 15 s in 43 patients (61.43%) and no delay in 27 patients (30.77%). The median arteriovenous transit time in patients without cherry-red spots was 19.00 s, while it was 18.00 s in patients with cherry-red spots; there was no significant difference between these two groups (P = 0.727). There are multiple factors that could cause the absence of cherry-red spots in CRAO. The use of OCT to observe increased hyperreflectivity of the inner retina is the most effective imaging method for the early diagnosis of CRAO without cherry-red spots.

Sections du résumé

BACKGROUND BACKGROUND
Cherry-red spots are a very important sign for the clinical diagnosis of central retinal artery occlusion (CRAO). We retrospectively summarized the clinical manifestations of CRAO and analysed the causes and characteristics of CRAO without cherry-red spots. In this study, we explored a diagnostic method for CRAO without cherry red spots.
METHODS METHODS
Seventy patients (70 eyes) with CRAO were examined retrospectively. Corrected distance visual acuity, fundus photos, FA and OCT images were collected at the first outpatient visit. The causes of CRAO without cherry-red spots were analysed through fundus photos. The incidence of increased hyperreflectivity of the inner retina, central macular thickness (CMT) and arteriovenous transit time in patients with and without cherry-red spots were compared.
RESULTS RESULTS
Fundus examination showed posterior retinal whitening in 57 cases (81.43%) and cherry-red spots in 39 cases (55.71%). Thirty-one patients presented at the first outpatient visit without cherry-red spots. The reasons for the absence of cherry-red spots included leopard fundus (32.26%), retinal vein occlusion (25.81%), no obvious inner retinal coagulative necrosis (19.35%), ciliary retinal artery sparing (12.90%), high macular oedema (9.68%) and cherry-red spot enlargement (3.23%). OCT revealed increased hyperreflectivity of the inner retina in 67 CRAO patients (95.71%). All 3 patients without increased hyperreflectivity of the inner retina did not present with cherry-red spots at the first visit. The median CMT in patients without cherry-red spots was 166.00 μm, while the median MCT in patients with cherry-red spots was 180.00 μm; there was no significant difference between these two groups (P = 0.467). FA showed delayed arteriovenous transit time > 23 s in 20 patients (28.57%), > 15 s in 43 patients (61.43%) and no delay in 27 patients (30.77%). The median arteriovenous transit time in patients without cherry-red spots was 19.00 s, while it was 18.00 s in patients with cherry-red spots; there was no significant difference between these two groups (P = 0.727).
CONCLUSIONS CONCLUSIONS
There are multiple factors that could cause the absence of cherry-red spots in CRAO. The use of OCT to observe increased hyperreflectivity of the inner retina is the most effective imaging method for the early diagnosis of CRAO without cherry-red spots.

Identifiants

pubmed: 37880636
doi: 10.1186/s12886-023-03176-w
pii: 10.1186/s12886-023-03176-w
pmc: PMC10601202
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

434

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

BMC Ophthalmol. 2018 Apr 18;18(1):101
pubmed: 29669523
Retina. 2007 Mar;27(3):276-89
pubmed: 17460582
Ocul Immunol Inflamm. 2012 Oct;20(5):384-6
pubmed: 22957726
Surv Ophthalmol. 2014 Jan-Feb;59(1):64-76
pubmed: 24011710
Dev Ophthalmol. 2016;56:122-31
pubmed: 27023788
Ophthalmology. 1991 Jul;98(7):1139-42
pubmed: 1891225
Med Hypothesis Discov Innov Ophthalmol. 2019 Winter;8(4):283-290
pubmed: 31788490
Exp Eye Res. 2004 Mar;78(3):723-36
pubmed: 15106952
Retina. 2015 Nov;35(11):2339-46
pubmed: 26457398
BMJ Case Rep. 2016 Aug 10;2016:
pubmed: 27511757
Am J Ophthalmol. 2005 Sep;140(3):376-91
pubmed: 16138997

Auteurs

Wei Fan (W)

Department of Ophthalmology, The Second Affiliated Hospital of Army Medical University, 183th, Xinqiao street, Shapingba District, 400037, Chongqing, China.

Yanming Huang (Y)

Department of Ophthalmology, The Second Affiliated Hospital of Army Medical University, 183th, Xinqiao street, Shapingba District, 400037, Chongqing, China.

Yuancheng Zhao (Y)

Department of Ophthalmology, The Second Affiliated Hospital of Army Medical University, 183th, Xinqiao street, Shapingba District, 400037, Chongqing, China.

Rongdi Yuan (R)

Department of Ophthalmology, The Second Affiliated Hospital of Army Medical University, 183th, Xinqiao street, Shapingba District, 400037, Chongqing, China. yuanrongdi755633@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH